Atlas Trials

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551

Clinical trial NCT00860353 · TERMINATED

Trial details

NCT number
NCT00860353
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2009-02-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.